Cellular Biotechnology Lab (@LAB_BIOC) header
Cellular Biotechnology Lab (@LAB_BIOC) profile picture

Cellular Biotechnology Lab

@LAB_BIOC

Cellular Biotechnology Lab at ISCIII Pediatric Cancer / Advanced Therapy / Immunotherapy https://xitter.gq/t.co/kalE8dtJnL

 Madrid - Spain
Joined April 2023
  • Tweets273
  • Following168
  • Followers141
51Media
Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)Photo by Cellular Biotechnology Lab (@LAB_BIOC)
Hoy arranca la jornada principal del Encuentro Internacional sobre Terapias Avanzadas, que celebramos en nuestro campus de Majadahonda. @red_terav Más de 1️⃣0️⃣0️⃣ expertos se reúnen para compartir avances en terapias y salas blancas al servicio de los pacientes.
Image from Instituto de Salud Carlos III (ISCIII) (@SaludISCIII)
Image from Instituto de Salud Carlos III (ISCIII) (@SaludISCIII)
1
7
2
14
948
Cellular Biotechnology Lab retweeted
Eva Bermejo-Sánchez, PhD (@EvaBS14) profile picture
Eva Bermejo-Sánchez, PhD@EvaBS1427 May 2025
El Instituto de Salud Carlos III (ISCIII) acoge un encuentro internacional sobre terapias avanzadas. Organizado por el #IIER, con el apoyo de la Red Española de terapias Avanzadas (Red TERAV+ ISCIII). isciii.es/documents/d/guest/… @JavierGC280 @l_marinas
Image from Eva Bermejo-Sánchez, PhD (@EvaBS14)
1
4
67
Cellular Biotechnology Lab retweeted
Javier García Castro (@JavierGC280) profile picture
Javier García Castro@JavierGC2808 Apr 2025
🔬 Workshop on Adoptive Cell Therapies! 🔬 Open scientific workshop on May 28, 2025, hosted at the Majadahonda Campus of ISCIII (Madrid-Spain). 🎟️ Free access — but registration is required via email: [email protected]
Image from Javier García Castro (@JavierGC280)
Image from Javier García Castro (@JavierGC280)
8
10
516
Cellular Biotechnology Lab retweeted
Amaya Mendikoetxea UAM (@_amayamendiko) profile picture
Amaya Mendikoetxea UAM@_amayamendiko2 Mar 2025
La inversión en ciencia es rentable. Barcelona: un ejemplo a seguir 👇
Image from Amaya Mendikoetxea UAM (@_amayamendiko)
21
2
49
3,875
Cellular Biotechnology Lab retweeted
Javier García Castro (@JavierGC280) profile picture
Javier García Castro@JavierGC28019 Feb 2025
Hace 20 años que creamos nuestra Fundación. Hoy nos unimos a la UAM para seguir apoyando la investigación, los tratamientos y la formación en Oncología Pediátrica Siempre agradecido de como me acogieron en el HNJS y los excelentes médicos que conocí y con los que sigo colaborando
FundaciónUAM (@fuam_uam) profile pictureFundaciónUAM@fuam_uam18 Feb 2025
La @UAM_Madrid y @CatedraUAMFOI presentan una cátedra pionera en el ámbito de la #salud infantil, que promoverá la #investigación, formación y divulgación en el campo de las enfermedades #oncohematológicas que afectan a niños y adolescentes. Más Info: fuam.es/noticias/nace-la-cat…
Image from FundaciónUAM (@fuam_uam)
Image from FundaciónUAM (@fuam_uam)
Image from FundaciónUAM (@fuam_uam)
Image from FundaciónUAM (@fuam_uam)
1
9
173
Cellular Biotechnology Lab retweeted
Cellular Biotechnology Lab (@LAB_BIOC) profile picture
Cellular Biotechnology Lab@LAB_BIOC15 Feb 2025
Clonal expansion of CD8+ T cells is an immunological driver of bispecific T cell engagers (TCE) Naive T cells require additional MHC class I signal and differentiate upon TCE activation Exhausted CD8+ clones predicts response failure in multiple myeloma cell.com/cancer-cell/fulltex…
The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple...

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple...

Bispecific T cell engagers (TCEs) have shown promise in the treatment of various cancers, but their mode of action in humans is elusive. Providing new insight into immunological mechanisms, Friedrich...

cell.com
1
2
124
Cellular Biotechnology Lab retweeted
Waggoner Lab (@LabWaggoner) profile picture
Waggoner Lab@LabWaggoner31 Jan 2025
CAR trogocytosis transfers antitumor immunity between T cells and is dictated by their transmembrane domain @SciImmunology science.org/doi/10.1126/scii…
Image from Waggoner Lab (@LabWaggoner)
31
3
139
24,918
Cellular Biotechnology Lab retweeted
Waggoner Lab (@LabWaggoner) profile picture
Waggoner Lab@LabWaggoner2 Feb 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies nature.com/articles/s41467-0…
Image from Waggoner Lab (@LabWaggoner)
25
70
4,325
Cellular Biotechnology Lab retweeted
GELTAMO (@geltamo) profile picture
GELTAMO
@geltamo7 Oct 2024
Aggressive Lymphoma after CD19 CAR T-Cell Therapy | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
Aggressive Lymphoma after CD19 CAR T-Cell Therapy | NEJM

Aggressive Lymphoma after CD19 CAR T-Cell Therapy | NEJM

The development of a fatal, clonal, autonomously proliferating CD4−CD8− chimeric antigen receptor (CAR)+ peripheral T-cell lymphoma (PTCL) occurred 1 month after a patient received treatment with t...

nejm.org
10
1
19
1,263
Cellular Biotechnology Lab retweeted
Waggoner Lab (@LabWaggoner) profile picture
Waggoner Lab@LabWaggoner22 Jan 2025
Mitochondrial respiratory complex III sustains IL-10 production in macrophages and promotes tumor-mediated immune evasion @laoneill111 @ZottaAlessia @ScienceAdvances science.org/doi/10.1126/scia…
Image from Waggoner Lab (@LabWaggoner)
1
15
2
94
4,701
Cellular Biotechnology Lab retweeted
Javier García Castro (@JavierGC280) profile picture
Javier García Castro@JavierGC28024 Jan 2025
Formación en oncohematología, incluyendo tratamientos CAR T.
Image from Javier García Castro (@JavierGC280)
Image from Javier García Castro (@JavierGC280)
3
4
120
Cellular Biotechnology Lab retweeted
Waggoner Lab (@LabWaggoner) profile picture
Waggoner Lab@LabWaggoner12 Dec 2024
‘cross-resistant’ tumor cells release lipids that reprogram cells called monocytes to stop them from activating tumor-targeting T cells nature.com/articles/d41586-0… nature.com/articles/s41586-0…
Image from Waggoner Lab (@LabWaggoner)
1
29
1
110
7,122
Cellular Biotechnology Lab retweeted
Journal for ImmunoTherapy of Cancer (@jitcancer) profile picture
Journal for ImmunoTherapy of Cancer
@jitcancer3 Dec 2024
New #JITC article: Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response bit.ly/4f2Eu7g
Image from Journal for ImmunoTherapy of Cancer (@jitcancer)
5
14
1,931
Cellular Biotechnology Lab retweeted
APU Pablo Ugarte (@APUpablougarte) profile picture
APU Pablo Ugarte@APUpablougarte23 Oct 2024
Mariano Ugarte, Presidente de la APU, nos anima a participar en la marcha #CerroMarmota24 el próximo domingo 24 de noviembre en Colmenar Viejo, y así pasar un gran día y a la vez colaborar con la investigación del cáncer infantil. Puedes inscribirte aqui: asociacionpablougarte.es/car…
9
2
22
719
Cellular Biotechnology Lab retweeted
SETGyC (@SETGyC) profile picture
SETGyC@SETGyC17 Oct 2024
🇪🇺 Our President Paula Rio (@PauFerrol) has been nominated as a candidate for the @ESGCT Board. It’s time to vote for Paula! 🗳️ ESGCT members can vote until Tuesday, October 22 for their Board representatives, who will serve a 3-year term.
Image from SETGyC (@SETGyC)
1
17
2
31
3,169
Cellular Biotechnology Lab retweeted
Waggoner Lab (@LabWaggoner) profile picture
Waggoner Lab@LabWaggoner11 Oct 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy @NatureBiotech @michal_bassani nature.com/articles/s41587-0… nature.com/articles/s41587-0…
Image from Waggoner Lab (@LabWaggoner)
30
3
108
10,978
Cellular Biotechnology Lab retweeted
APU Pablo Ugarte (@APUpablougarte) profile picture
APU Pablo Ugarte@APUpablougarte11 Oct 2024
Marcha y carrera solidaria #CerroMarmota24, a favor de la investigacion infantil. Dónde? En Colmenar Viejo Cuándo? Domingo 23 de noviembre APÚNTATE aquí 👇👇👇 asociacionpablougarte.es/car…
Image from APU Pablo Ugarte (@APUpablougarte)
4
1
9
280
Cellular Biotechnology Lab retweeted
APU Pablo Ugarte (@APUpablougarte) profile picture
APU Pablo Ugarte@APUpablougarte10 Oct 2024
📽📽 Vídeo explicativo de los proyectos de investigación que financia la APU en el Hospital Niño Jesús de Madrid y que tienen que ver con tumores sólidos: inmunoterapias y nanotecnología. m.youtube.com/watch?v=diYDBG…
Image from APU Pablo Ugarte (@APUpablougarte)
5
1
10
414
Cellular Biotechnology Lab retweeted
Li Tang (@Tang_Lab_EPFL) profile picture
Li Tang@Tang_Lab_EPFL7 Oct 2024
Thrilled to share our back-to-back two Nature @Nature papers on the unexpected role of type 2 immunity against cancer. We found that interleukin 4 (Fc–IL-4), a type 2 cytokine, reinvigorates exhausted T cells to potentiate anticancer immunotherapy w/ @YugangGUO2 @RongFan8(1/11)
Image from Li Tang (@Tang_Lab_EPFL)
14
79
4
504
57,100
Cellular Biotechnology Lab retweeted
Nature Biotechnology (@NatureBiotech) profile picture
Nature Biotechnology
@NatureBiotech8 Oct 2024
The FDA’s approval of the first genetically modified T cell therapy for treating a rare sarcoma is paving the way for next-generation therapies that tackle other types of solid tumors nature.com/articles/s41587-0…
TCR cell therapies vanquish solid tumors — finally

TCR cell therapies vanquish solid tumors — finally

Nature Biotechnology - The FDA’s approval of the first genetically modified T cell therapy for treating a rare sarcoma is paving the way for next-generation therapies that tackle other types...

nature.com
1
83
6
285
42,180
Load more